Literature DB >> 9365758

Secondary colony formation after long-term bone marrow culture using peripheral blood and bone marrow of HIV-infected patients.

E M Sloand1, N S Young, T Sato, P Kumar, S Kim, F F Weichold, J P Maciejewski.   

Abstract

OBJECTIVE: To determine if defective bone marrow function in HIV infection is associated with decreased numbers of progenitor cells or defective stromal cell function.
DESIGN: Defective bone marrow function may in part be responsible for the cytopenias so frequently seen in patients with AIDS. Although a number of investigators have reported impaired growth of committed hematopoietic progenitor cells in HIV-1-infected patients, few studies have examined the most primitive hematopoietic stem cells. Our study was designed to determine the function and quality of the most immature hematopoietic progenitor and stem cells in the peripheral blood and bone marrow of HIV-1-infected patients and to assess stromal cell function.
METHODS: For quantification of these cells we used a modified long-term culture-initiating cell (LTCIC) assay in which the number of secondary colony-forming cells after 5 weeks of stromal culture served as a measure of LTCIC. Stromal cells from normal controls and HIV-1-infected patients were used for cross-matching experiments. Normal CD34+ cells or those derived from HIV-infected patients were plated and colony growth assessed.
RESULTS: We found that HIV-1-infected patients had a mean of 0.8 secondary colony-forming cells/10(5) peripheral blood mononuclear cells (PBMC), whereas normal controls showed 1.2 secondary colony-forming cells/10(5) PBMC (P = not significant) after long-term culture. Asymptomatic patients showed well preserved numbers of secondary colony-forming cells after long-term culture of PBMC, but a significant reduction was seen in patients with a history of opportunistic infections (P < 0.01), low CD4+ cell count (< 200 x 10(6)/l; P < 0.05), or leukopenia (P < 0.05). Decreased numbers of secondary colony-forming cells have also been found in bone marrow of HIV-1-infected patients with advanced disease. When normal CD34+ cells were cultured on stromal layers from bone marrow of HIV-1-infected patients or normal controls, no differences in the numbers of surviving progenitor cells were found.
CONCLUSIONS: Our data indicate that the hematopoietic defect in HIV-1 infection involves the most immature hematopoietic cells and becomes evident in advanced disease. Stromal function of HIV-infected patients appears normal.

Entities:  

Mesh:

Year:  1997        PMID: 9365758     DOI: 10.1097/00002030-199713000-00002

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  12 in total

1.  Early and persistent bone marrow hematopoiesis defect in simian/human immunodeficiency virus-infected macaques despite efficient reduction of viremia by highly active antiretroviral therapy during primary infection.

Authors:  H Thiebot; F Louache; B Vaslin; T de Revel; O Neildez; J Larghero; W Vainchenker; D Dormont; R Le Grand
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

2.  Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome.

Authors:  Elaine M Sloand; Lori Mainwaring; Monika Fuhrer; Shakti Ramkissoon; Antonio M Risitano; Keyvan Keyvanafar; Jun Lu; Atanu Basu; A John Barrett; Neal S Young
Journal:  Blood       Date:  2005-04-12       Impact factor: 22.113

3.  Increased soluble urokinase plasminogen activator receptor (suPAR) is associated with thrombosis and inhibition of plasmin generation in paroxysmal nocturnal hemoglobinuria (PNH) patients.

Authors:  Elaine M Sloand; Loretta Pfannes; Phillip Scheinberg; Kenneth More; Colin O Wu; McDonald Horne; Neal S Young
Journal:  Exp Hematol       Date:  2008-10-26       Impact factor: 3.084

Review 4.  Neutropenia during HIV infection: adverse consequences and remedies.

Authors:  Xin Shi; Matthew D Sims; Michel M Hanna; Ming Xie; Peter G Gulick; Yong-Hui Zheng; Marc D Basson; Ping Zhang
Journal:  Int Rev Immunol       Date:  2014-03-21       Impact factor: 5.311

5.  Is Nef the elusive cause of HIV-associated hematopoietic dysfunction?

Authors:  Frank Kirchhoff; Guido Silvestri
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

6.  Human and simian immunodeficiency viruses deregulate early hematopoiesis through a Nef/PPARgamma/STAT5 signaling pathway in macaques.

Authors:  Stéphane Prost; Mikael Le Dantec; Sylvie Augé; Roger Le Grand; Sonia Derdouch; Gwenaelle Auregan; Nicole Déglon; Francis Relouzat; Anne-Marie Aubertin; Bernard Maillere; Isabelle Dusanter-Fourt; Marek Kirszenbaum
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

7.  Chimeric SCID-hu Model as a Human Hematopoietic Stem Cell Host That Recapitulates the Effects of HIV-1 on Bone Marrow Progenitors in Infected Patients.

Authors:  I Birgitta Sundell; Prasad S Koka
Journal:  J Stem Cells       Date:  2006

8.  Stem cell mobilization in HIV seropositive patients with lymphoma.

Authors:  Alessandro Re; Chiara Cattaneo; Cristina Skert; Pascual Balsalobre; Mariagrazia Michieli; Mark Bower; Andrés J M Ferreri; Marcus Hentrich; José M Ribera; Bernardino Allione; Philipp Schommers; Silvia Montoto; Camillo Almici; Pierino Ferremi; Mario Mazzucato; Salvatore Gattillo; Salvatore Casari; Michele Spina; José L Diez-Martin; Umberto Tirelli; Giuseppe Rossi
Journal:  Haematologica       Date:  2013-08-23       Impact factor: 9.941

9.  Mesenchymal stem cell derived hematopoietic cells are permissive to HIV-1 infection.

Authors:  Timo Z Nazari-Shafti; Eva Freisinger; Upal Roy; Christine T Bulot; Christiane Senst; Charles L Dupin; Abigail E Chaffin; Sudesh K Srivastava; Debasis Mondal; Eckhard U Alt; Reza Izadpanah
Journal:  Retrovirology       Date:  2011-01-12       Impact factor: 4.602

10.  B- and T-lymphocyte number and function in HIV+/HIV- lymphoma patients treated with high-dose chemotherapy and autologous bone marrow transplantation.

Authors:  Diego Bertoli; Alessandro Re; Marco Chiarini; Alessandra Sottini; Federico Serana; Viviana Giustini; Aldo M Roccaro; Chiara Cattaneo; Luigi Caimi; Giuseppe Rossi; Luisa Imberti
Journal:  Sci Rep       Date:  2016-12-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.